ArticleNature communications2023
Programming actuation onset of a liquid crystalline elastomer via isomerization of network topology.
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Liquid Crystal Elastomers for Adaptive Intelligent Systems: From Molecular Design to Multifunctional Applications.Angewandte Chemie (International ed. in English) · 2026Review
- High-strength, programmable energy-dissipating liquid crystal elastomers via hydrogen-bond-locked 4D printing.iScience · 2026Article
- A supramolecular non-mesogenic route towards autonomous liquid crystal elastomer soft robots.Nature communications · 2026Article
- Leveraging catechol chemistry to tackle toughness-softness-work capacity tradeoff in reprogrammable liquid crystal actuators.Nature communications · 2025Article
- Theoretical Modeling of a Bionic Arm with Elastomer Fiber as Artificial Muscle Controlled by Periodic Illumination.Polymers · 2025Article
- Impact of pre-crosslinks on the self-transformation performance of thermoplastic polyesters into vitrimersRSC advances · 2025Article
- Embedded Physical Intelligence in Liquid Crystalline Polymer Actuators and Robots.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Fibrillar adhesives with unprecedented adhesion strength, switchability and scalability.National science review · 2024Article
- Rejuvenating liquid crystal elastomers for self-growth.Nature communications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Tuning actuation temperatures of liquid crystalline elastomers (LCEs) achieves control of their actuation onsets, which is generally accomplished in the synthesis step and cannot be altered afterward. Multiple actuation onsets in one LCE can be encoded if the post-synthesis regulation of actuation temperature can be spatiotemporally achieved. This would allow realizing a logical time-evolution of actuation, desired for future soft robots. Nevertheless, this task is challenging given the additional need to ensure mesogen alignment required for actuation. We achieved this goal with a topology isomerizable network (TIN) of LCE containing aromatic and aliphatic esters in the mesogenic and amorphous phases, respectively. These two ester bonds can be distinctly activated for transesterification. The homolytic bond exchange between aliphatic esters allows mechanically induced mesogen alignment without affecting the mesogenic phase. Most importantly, the heterolytic exchange between aromatic and aliphatic esters changes the actuation temperature under different conditions. Spatial control of the two mechanisms via a photo-latent catalyst unleashes the freedom in regulating actuation temperature distribution, yielding unusual controllability in actuation geometries and logical sequence. Our principle is generally applicable to common LCEs containing both aromatic and aliphatic esters.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.